tirzepatide vs semaglutide Semaglutide: Weight Loss, Side Effects & Cost (2026) Comparative Cardiovascular Pharmacovigilance of Semaglutide

Several agents have shown cardiovascular outcome benefits in select populations, which guides therapy selection for people with existing atherosclerotic cardiovascular disease

Both are disease states

Selected Research References Wilding JPH, et al

Answer: Tirzepatide is generally considered for adults with obesity, or who are overweight with a related health condition, used alongside diet and activity changes

The Pure Medical Spa Advantage Our virtual weight loss program, focused on effective treatments like Wegovy and Zepbound, offers significant benefits: Expert Medical Supervision: Every patient receives a comprehensive medical review and ongoing care from licensed healthcare providers who specialize in treating obesity with GLP-1 agonists